TAK-700

Orteronel · Millennium Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for TAK-700, covering 2016-04-04 to 2019-07-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer [Phase 1, Phase 2]

See pricing